Quarterly pharmacy formulary change notice

Similar documents
Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Aetna Better Health of Florida Supplemental Preferred Drug List

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change

Pharmacy Updates Summary

Oral Agents. Formulary Limits. Available Strengths. IR: 4mg ER: 12mg Syrup: 2mg/5ml

Oral Agents. Fml Limits. Available Strengths NF NF

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Health Partners Medicare Prime 2019 Formulary Changes

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Pharmacy Updates Summary

ANTIEMETICS STEP. Step Therapy Requirements Effective April 1, 2019

Quarterly pharmacy formulary change notice

1, 2014 PHARMACY BENEFIT

Quarterly pharmacy formulary change notice

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

Quarterly pharmacy formulary change notice

August 2016 Formulary Updates

Quarterly pharmacy formulary change notice

Pequot Health Care Smart Quantity Program*

Clinical Policy: Antihistamines Reference Number: CP.HNMC.18 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT NOVEMBER 30, 2010

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details.

3 Tier Formulary Additions

Drug Formulary. A healthier you. A healthier community.

Important Pharmacy Information

Your prescription benefit updates Formulary Updates - Effective January 1, 2019

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

Aetna Better Health FIDA Plan

HOW TO USE THE FORMULARY

Office of Medicaid Policy and Planning Over-the-Counter Drug Formulary ANALGESICS ANTACIDS ANTI-FLATULENTS

UPDATE Ohana QUEST Integration Medicaid

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

Network Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary

Step Therapy Requirements. Effective: 05/01/2018

PDP Classic Formulary Addendum

Quarterly pharmacy formulary change notice

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

WVCH Formulary Additions Effective 01/01/2016 Name Strength Dosage Form Route Formulary Restrictions

ALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018

2018 Step Therapy FID 18088

Triage Information: 1. Duration of HPSJ Membership 2. Age 3. Fill history of Seasonal Allergy Medications

High-Cost Drug Exclusions

Quarterly pharmacy formulary change notice

Drug Name Tier Drug Name Tier

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Aetna Better Health of Illinois Medicaid Formulary Updates

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

BLUE SHIELD OF CALIFORNIA JUNE 2016 PLUS DRUG FORMULARY CHANGES

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT

AGGRENOX. Products Affected. Details. GRP B2 Last Updated: 09/01/2018. Aggrenox

Medication Prior Authorization Form

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

2019 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST

2018 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST

March 2017 Pharmacy & Therapeutics Committee Decisions

VIVA Health, Inc. Part D Cumulative Formulary Changes for 2009

WellCare s South Carolina Preferred Drug List Update

Quarterly pharmacy formulary change notice

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)

2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015

Step Therapy Approval Criteria

MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS

Price List Effective 1June 2011.

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

LYSIS OF ADHESIONS POST-OP PLAN - Phase: PACU Phase

ANTIDIABETIC AGENTS - MISCELLANEOUS

Gonadotropin Releasing Hormone (GnRH) Analogs Drug Class Prior Authorization Protocol

ANTIDIABETIC AGENTS - MISCELLANEOUS

Quarterly Pharmacy Formulary Change Notice

AGGRENOX. Products Affected. Details. First Health Part D Value Plus (PDP) Last Updated: 10/01/2017. Aggrenox

Drug Class Monograph

Data Class: Internal. 1 inhaler (30 blisters OR 14 blisters institutional pack) per presciption

Neighborhood Medicaid Formulary Changes: June 2017

Effective for all members on November 1, 2017

Transcription:

Provider update This is an update about information in the provider manual. For access to the latest provider manual, go online to https://providers.amerigroup.com/md. Quarterly pharmacy formulary change notice Summary of change: The formulary changes listed in the table below were reviewed and approved at our June 27, 2016, Pharmacy and Therapeutics Committee (P&T) meeting. What this means to you: Effective November 1, 2016, the changes outlined below apply to all Amerigroup Community Care patients. What is the impact of this change? THERAPEUTIC CLASS RESPIRATORY SPACERS PROTON PUMP ALCOHOL PREP PADS ALKYLATING Effective for all patients on November 1, 2016 MEDICATION SPACERS: AEROCHAMBER AEROCHAMBER Z-STAT PLUS AEROCHAMBER PLUS EASIVENT E-Z SPACER FLEXICHAMBER INSPIRACHAMBER PANTOPRAZOLE SOD DR 20 MG TAB PANTOPRAZOLE SOD DR 40 MG TAB ONE PHARMACEUTICAL PHOENIX HEALTHCARE SPECIALTY MED HOME AID DIAGNOSTICS SIMPLE DIAGNOSTICS REVISED STATUS POTENTIAL ALTERNATIVES OPTICHAMBER DIAMOND POCKET CHAMBER VORTEX LITEAIRE MICROSPACER MICROCHAMBER BREATHERITE NEXIUM 24HR 20 MG TABLET (OTC) NEXIUM 24HR 22.3 MG (OTC) OMEPRAZOLE MAG DR 20.6 MG CAP (OTC) OMEPRAZOLE DR 20 MG TABLET (OTC) PREVACID 24HR DR 15 MG (OTC) HEARTBURN TREATMNT 24HR 15 MG (OTC) MCKESSON DRUG TARGET CORP. RITE AID CORP. WALGREEN CO. LEADER CVS WAL-MART STORES BD DIABETES CYCLOPHOSPHAMIDE CAPS PREFERRED https://providers.amerigroup.com MDPEC-1187-16 October 2016

ALPHA PROTEINASE INHIBITOR PROLASTIN C 1;000 MG VIAL ANTIDIURETIC AND VASOPRESSOR HORMONES ANTIFUNGAL ANTIHYPERTENSIVE ANTIMETABOLITES ANTIMETABOLITES ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS INJECTIONS DRUGS DRUGS ANTIPSORIATIC/ ANTISEBORRHEIC ANTIVERTIGO & ANTIEMETIC DDAVP 0.2 MG TABLET MYCELEX TROCHE NOXAFIL 40 MG/ML SUSPENSION TARKA ER 2-180 MG TABLET NICARDIPINE 30 MG PRINIVIL 5 MG TABLET PRINIVIL 10 MG TABLET PRINIVIL 20 MG TABLET ZESTORETIC 10-12.5 MG METHOTREXATE INJ TABLOID TABLET TREXALL TABLET ADRUCIL VIAL FLUOROURACIL VIAL GEMCITABINE VIAL ZEMBRACE SYMTOUCH ONZETRA XSAIL NASAL SPRAY PREFFERED STEP THERAPY (ST) REQUIRED IMITREX 6 MG/0.5 ML VIAL AVASTIN 100 MG/4 ML VIAL AVASTIN 400 MG/16 ML VIAL LEUPROLIDE 2WK 1 MG/0.2 ML KIT HERCEPTIN 440 MG VIAL INTRON VIALS LEUPROLIDE 2WK 1 MG/0.2 ML KIT LUPRON DEPOT KITS SYNRIBO 3.5 MG/ML VIAL TORISEL 25 MG KIT TRELSTAR SYRINGE VECTIBIX VIAL ZALTRAP VIAL ZOLADEX IMPLANT SYRN SIGNIFOR LAR VIAL SOMATULINE DEPOT FIRMAGON KIT SANDOSTATIN AMPULS/VIALS SANDOSTATIN LAR DEPOT VIALS TALTZ 80 MG/ML AUTOINJECTOR TALTZ 80 MG/ML SYRINGE EMEND EMEND TRIPACK EMEND 150 MG VIAL ADD PA AND QL ADD PA AND QL Page 2 of 5

BARBITURATE COMBINATION CHEMOTHERAPY RESCUE/ANTIDOTE DERMATOLOGICALS GNRH GROWTH HORMONE RECEPTOR ANTAGONISTS BUTALBITAL-ACETAMINOPHEN 25-325 MG 300 MG TABLET 325 MG TABLET 650 MG CAFFEINE 50 MG-325 MG-40 MG/15 ML SOLUTION CAFFEINE 50 MG-300 MG-40 MG CAFFEINE 50 MG-325 MG-40 MG CAFFEINE 50 MG-325 MG-40 MG TABLET BUTALBITAL-ASPIRIN-CAFFEINE 50 MG- 325 MG-40 MG BUTALBITAL-ASPIRIN-CAFFEINE- CODEINE 50 MG-325 MG-40 MG-30 MG VISTOGARD 10 GRAM PACKET CARAC 0.5% CREAM EFUDEX 5% CREAM TOLAK 4% CREAM FLUOROURACIL 5% TOP SOLUTION FLUOROURACIL 2% TOPICAL SOLN FLUOROPLEX 1% CREAM ALDARA 5% CREAM PICATO 0.015% GEL PICATO 0.05% GEL SOLARAZE 3% GEL LUPANETA PACK 3.75/5 MG LUPANETA PACK 11.25/5 MG LUPRON DEPOT PED 30 MG LUPRON DEPOT PED 11.25 OR 15 MG LUPRON DEPOT 7.5 MG LUPRON DEPOT 11.25 MG, 22.5 MG LUPRON DEPOT 30 MG SUPPRELIN LA SYNAREL SOMAVERT 10MG, 15MG, 20MG, 25MG, 30MG Page 3 of 5

LAXATIVES AND CATHARTICS MIRALAX MITOTIC NASAL STEROIDS NON-SEDATING ANTIHISTAMINES (NSA) CHEMET DESFERAL IXEMPRA 15 MG KIT IXEMPRA 45 MG KIT RHINOCORT ALLERGY (OTC) NASONEX/ MOMETASONE CLARINEX 0.5 MG/ML (2.5 MG/5) CHILD'S CLARITIN 5 MG TAB CHEW CLARITIN 5 MG REDITABS PA REQUIRED FEXOFENADINE HCL 60 MG TABLET (OTC) FEXOFENADINE HCL 180 MG TABLET (OTC) LORATADINE ALLERGY 5 MG/5 ML (OTC) LORATADINE 10 MG ODT (OTC) NSAIDS VIVLODEX OPHTHALMIC ANGIOGENESIS OSTEOPOROSIS THERAPY OSTEOPOROSIS THERAPY SKELETAL MUSCLE RELAXANTS TOPICAL ANTI- INFLAMMATORY- NSAIDS LUCENTIS 0.5 MG VIAL LUCENTIS 0.3 MG VIAL ALENDRONATE SOD 70 MG/75 ML PREFERRED FORTEO 600 MCG/2.4 ML PEN INJ AMRIX 30MG METHOCARBAMOL 750 MG FLECTOR PATCH PENNSAID 1.5% PENNSAID 2% VOLTAREN GEL PAH TYVASO INHALATION PAH PRENATAL VITAMINS PROTON PUMP ATROVENT HFA ATROVENT SOLUTION ENBRACE HR FOCALGIN 90 DHA COMBO PACK; FOCALGIN CA COMBO PACK NIVA-PLUS OB COMPLETE GOLD PREFERA-OB PLUS DHA COMBO PACK PROVIDA DHA TRISTART DHA VITAFOL FE + DOCUSATE COMBO PACK LETAIRIS 5 MG TABLET LETAIRIS 10 MG TABLET DEXILANT SOLUTAB Page 4 of 5

RH IMMUNE GLOBULIN RHEUMATOLOGICA L RHEUMATOLOGICA L MICRHOGAM ULTRA-FILTD PLUS SYR RHOGAM ULTRA-FILTERED WINRHO SDF HYPERRHO S-D RHOPHYLAC 300 MCG/2 ML SYRINGE KINERET 100 MG/0.67 ML SYRINGE XELJANZ XR TABLET ADD PA AND QL UTI PROPHYLAXIS NITROFURANTOIN MCR 25 MG CAP PREFERRED UTI PROPHYLAXIS NITROFURANTOIN 25 MG/5 ML SUSP VACCINES & IMMUNOLOGICALS CYTOGAM 2.5 GM/50 ML VIAL What action do I need to take? Please review these changes and work with your Amerigroup patients to transition them to formulary alternatives. If you determine preferred formulary alternatives are not clinically appropriate for specific patients, you will need to obtain prior authorization to continue coverage beyond the applicable effective date. What if I need assistance? We recognize the unique aspects of patients cases. If, for medical reasons, your Amerigroup patient cannot be converted to a formulary alternative, call our Pharmacy department at 1-800-454-3730 and follow the voice prompts for pharmacy prior authorization. You can find the preferred drug list on our provider website at https://providers.amerigroup.com/md. If you need assistance with any other item, contact your local Provider Relations representative or call Provider Services at 1-800-454-3730. Page 5 of 5